Engineered T-Cells: A look at Autologous and Allogeneic CAR-T Cell Immunotherapies
Re-tasking our body’s own immune system to treat cancer has been a major scientific goal over the last few decades. According to the National Cancer Institute, it is estimated that 1,735,350 new cases of cancer were diagnosed, and 609,640 deaths were reported in the US in 20181. One of the most revolutionary approaches to date […]